ACHP Comments on Medicare Drug Price Negotiation Rule

ACHP has long championed meaningful drug pricing reform, including Medicare price negotiation for drugs without generic or biosimilar competition. We support efforts to strengthen the program while preserving health plans’ flexibility to manage formularies based on clinical evidence and value.